Skip to main content
. Author manuscript; available in PMC: 2018 Nov 1.
Published in final edited form as: Free Radic Biol Med. 2017 Aug 24;112:464–479. doi: 10.1016/j.freeradbiomed.2017.08.013

Figure 3.

Figure 3

Analysis of breast cancer data by Kaplan-Meier Plotter (http://kmplot.com) shows that low EcSOD expression is significantly associated with poor outcome (relapse free survival, RFS) in all types of breast cancer examined. Left panel shows analyses performed on all patients regardless of treatments while systemically untreated patients were excluded in analyses shown on the right. In red, patients with expression above the median and in black, patients with expressions below the median. The numbers of samples in each group are indicated in parentheses, and the hazard ratios (HR) and log rank p values are shown. Gene expression data and survival information are downloaded from GEO (Affymetrix HGU133A and HGU133+2 microarrays), EGA and TCGA.